Home
Search results “Evista treatment for breast cancer” for the 2016
Evista 1
 
01:58
Views: 246 Quinton Martinez
2 More Side Effects of Tamoxifen
 
04:33
Find out more about Breast Cancer Index (BCI): http://www.breastcanceranswers.com/breastcancerindex/ As a continuation of our Hormone Therapy Side Effects Video, here are 2 more side effects from Tamoxifen you should be aware of. SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS http://www.youtube.com/user/drjayharness VISIT BREASTCANCERANSWERS.com FOR THE LATEST IN BREAKING BREAST CANCER NEWS http://www.breastcanceranswers.com/news SUBMIT A QUESTION http://www.breastcanceranswers.com/ DOWNLOAD DR. HARNESS' 15 QUESTIONS TO ASK YOUR DOCTOR http://www.breastcanceranswers.com/ CONNECT WITH US! Google+: http://bit.ly/16nhEnr Facebook: https://www.facebook.com/BreastCancerAnswers Twitter: https://twitter.com/BreastCancerDr
BREAST CANCER Symptoms and Treatments
 
05:49
Breast cancer is cancer that develops from breast tissue.[1] Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, or a red scaly patch of skin.[2] In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.[3] Risk factors for developing breast cancer include: female sex, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, and family history.[2][4] About 5–10% of cases are due to genes inherited from a person's parents, including BRCA1 and BRCA2 among others. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas.[2] In addition, there are more than 18 other sub-types of breast cancer. Some cancers develop from pre-invasive lesions such as ductal carcinoma in situ.[4] The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning lump. Once the diagnosis is made, further tests are done to determine if the cancer has spread beyond the breast and which treatments it may respond to.[2] The balance of benefits versus harms of breast cancer screening is controversial. A 2013 Cochrane review stated that it is unclear if mammographic screening does more good or harm.[5] A 2009 review for the US Preventive Services Task Force found evidence of benefit in those 40 to 70 years of age,[6] and the organization recommends screening every two years in women 50 to 74 years old.[7] The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it.[4] Surgical removal of both breasts is another useful preventative measure in some high risk women.[4] In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy.[2] Types of surgery vary from breast-conserving surgery to mastectomy.[8][9] Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.[9]
Views: 201 MedicTube
New Drug Combinations Found to Treat Breast Cancer
 
00:44
20 (UPI) -- Scientists have discovered a new way to fight drug resistance in the treatment of breast cancer through bioinformatics. Researchers from the Institute for Research in Biomedicine in Barcelona, Spain, studied cell signaling networks in an effort to combat breast cancer cells from becoming resistant to certain types of drug treatment. The study analyzed 64 drugs used to treat breast cancer and identified 10 new drug combinations that could aid in the treatment of drug-resistant breast cancer. Resistance develops in about 15 percent of cases, as the activation of alternative molecular signaling pathways allows tumor cells to divide and avoid cell death. http://www.upi.com/Health_News/2016/12/20/Study-highlights-new-drug-combinations-to-treat-breast-cancer/8261482251716/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Views: 244 Wochit News
How to pronounce raloxifene (Evista) (Memorizing Pharmacology Flashcard)
 
00:15
Pronunciation flashcards for the medications in the print, e-book, and pharmacology audiobook Memorizing Pharmacology: A Relaxed Approach. More difficult medication names will have two pronunciation videos, a flashcard short version and an extended version breaking the pronunciation down syllable by syllable.
Views: 1767 Tony PharmD
Breast Cancer Awareness : Causes, Symptoms and Treatments - Pink Ribbon Walk | YOYO TV Channel
 
04:07
Please watch: "Tollywood Producer D Suresh Babu Latest Interview | Nene Raju Nene Mantri | Rana, Kajal | YOYO TV" https://www.youtube.com/watch?v=EHXpV0MNUss -~-~~-~~~-~~-~- Pink ribbon walk giving awareness over breast cancer. Breast cancer is cancer that develops from breast tissue.Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, or a red scaly patch of skin In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin. Risk factors for developing breast cancer include being female, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, and family history. About 5–10% of cases are due to genes inherited from a person's parents, including BRCA1 and BRCA2 among others. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas. In addition, there are more than 18 other sub-types of breast cancer. Some cancers, such as ductal carcinoma in situ, develop from pre-invasive lesions. The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning lump. Once the diagnosis is made, further tests are done to determine if the cancer has spread beyond the breast and which treatments it may respond to. The balance of benefits versus harms of breast cancer screening is controversial. A 2013 Cochrane review stated that it is unclear if mammographic screening does more good or harm. A 2009 review for the US Preventive Services Task Force found evidence of benefit in those 40 to 70 years of age, and the organization recommends screening every two years in women 50 to 74 years old. The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it. Surgical removal of both breasts is another preventative measure in some high risk women. In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy.Types of surgery vary from breast-conserving surgery to mastectomy. Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort. Outcomes for breast cancer vary depending on the cancer type, extent of disease, and person's age. Survival rates in the developed world are high, with between 80% and 90% of those in England and the United States alive for at least 5 years. In developing countries survival rates are poorer. Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases.In 2012 it resulted in 1.68 million cases and 522,000 . It is more common in developed countries and is more than 100 times more common in women than in men. Please watch: "Srimathi Oka Bahumathi Webisode 3 With Etv Prabhakar || YOYO TV Channel" https://www.youtube.com/watch?v=iYGjgGWdvj0 Subscribe Us at https://goo.gl/VxNByu Like and Share at facebook: https://www.facebook.com/YOYOTVCHANNEL/
Views: 234 YOYO TV Channel
Pharmacodynamics of SERMs
 
04:12
-- Created using PowToon -- Free sign up at http://www.powtoon.com/youtube/ -- Create animated videos and animated presentations for free. PowToon is a free tool that allows you to develop cool animated clips and animated presentations for your website, office meeting, sales pitch, nonprofit fundraiser, product launch, video resume, or anything else you could use an animated explainer video. PowToon's animation templates help you create animated presentations and animated explainer videos from scratch. Anyone can produce awesome animations quickly with PowToon, without the cost or hassle other professional animation services require.
Views: 2564 Amilcar Thobejane
will nolvadex get rid of gyno
 
01:16
will nolvadex get rid of gyno
Views: 5051 Julian Bryant
Gynecomastia from Pro Hormones, Patient Examines Gland by Dr. Lebowitz, Long Island, New York
 
01:00
Pro Hormone Inducted Gynecomastia, Patient Examines his just Removed Gland. Pro Hormone Gynecomastia Gland is Hard and stuck to the muscle and skin!!!!!
Tamoxifen
 
06:58
This video is about cancer project
Views: 6958 lauren marple
Women’s Cancers: A Speed Science Panel
 
01:03:00
A three part panel session on topics related to cancers as they affect women. Anosheh Afghahi, MD, MPH provides an overview of breast cancer genetic testing and shares the latest advances in breast cancer screening and prevention. Sigurdis Haraldsdottir, MD discusses risk factors for colorectal cancer, treatment and prevention strategies and the role of precision health. Oliver Dorigo, MD discusses ovarian cancer, and the importance of using different treatments in combination and discovering new detection and monitoring methods. He also talks about how immunotherapy offers a new and promising strategy for treating ovarian tumors.
Views: 459 Stanford Medicine
raloxifene transdermal patches
 
01:06
Preparation and in- Vitro evaluation of raloxifene in the form of self nanoemulsion for transdermal delivery.
Views: 1185 Renad Alghamdi
Hormonal treatments produce similar quality of life outcomes in DCIS
 
07:56
Prof Ganz talks to ecancertv at SABCS 2015 about secondary end point data from the phase III NSABP B-35 clinical trial that compared 5 years’ treatment with anastrozole or tamoxifen in postmenopausal women with ductal carcinoma in situ (DCIS). The primary end point results of the NSABP B-35 trial were reported at the American Society of Clinical Oncology 2015 annual meeting and showed that anastrozole was at least as effective and safe as tamoxifen. There was a slight advantage of anastrozole perhaps, Dr Ganz notes in the interview. Indeed women where more likely to remain breast-cancer free at 10 years if they had received the aromatase inhibitor. Patient reported outcomes such as quality of life were reported in a sub-study of the trial and Dr Ganz reported data on more than 1000 women who has participated and completed the Short-Form 12. There were no differences, however, between the women treated with anastrozole and those treated with tamoxifen when using the Physical Component Summary (p=0.16) or the Mental Component Summary (p=0.38) of this questionnaire. As expected there were differences in terms of the symptoms, with the typical tamoxifen side effects of hot flashes seen and more musculoskeletal pain and vaginal pain and discomfort during sex in those treated with anastrozole. What these data show is that there are choices, Dr Ganz says. Before tamoxifen was the only approved option in DCIS but the NSABP B-35 and other trial data now show that aromatase inhibitor therapy, specifically anastrozole, is also of benefit.
Views: 183 ecancer
1803: Raloxifene or Alendronate
 
01:21
USMLE Step 1 Questions at http://www.latisom.com Life and Times in Schools of Medicine Inc. LATISOM offers a video streaming question bank for USMLE Step 1 and second year of medical school course work. Musculoskeletal system questions
Views: 47 latisom
Cancer and Family History: Using Genomics for Prevention
 
01:00:51
The risk factors for cancer are many and varied, and inherited genetic mutations play a major role in 5 to 10% of all cancers. When these mutations are identified early, patients are able to work with their healthcare providers to take crucial steps toward care and treatment. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at https://www.cdc.gov/video/phgr/2016/GR_04-19-2016-lo-res.mp4
Medications Available to Treat Osteoporosis, presented with National Osteoporosis Foundation
 
34:48
**NEEDYMEDS IS MOVING YOUTUBE CHANNELS** You can find this video here: https://youtu.be/-UxFPnm1myI You can many more from us in the future here: https://www.youtube.com/NeedyMeds This Special Topic Webinar was for National Osteoporosis Month. National Osteoporosis Foundation Clinical Director, Dr. Andrea Singer, will discuss the recently released Medicines in Development for Treatment of Osteoporosis Report and provide information on current medications available for the treatment of osteoporosis. We provide monthly overview webinars about the services and information NeedyMeds provides, as well as special topic webinars like this one. Check http://www.needymeds.org/webinar for more.
Views: 212 NeedyMeds
Zeynep Madak-Erdogan: ERα-XPO1 crosstalk in tamoxifen resistance
 
03:33
Dr. Madak-Erdogan, assistant professor of nutrition at the University of Illinois at Urbana-Champaign, talks about the research in an article she co-authored that is published in the October 2016 issue of the journal Molecular Endocrinology. The article focuses on finding therapeutic approaches to breast cancer that include novel, targetable, mechanism-based strategies by which the nuclear hormone estrogen receptor α (ERα) can be sensitized by endocrine therapies, specifically tamoxifen. ERα is present in approximately 70 percent of breast cancers and is considered one of the most critical predictive factors of breast cancer prognosis. You can read the article online at http://dx.doi.org/10.1210/me.2016-1101
SABCS 2015 Presentation with Dr. Nimmi Kapoor
 
03:17
Dr. Nimmi Kapoor from Breastlink gives a presentation on Multi-Gene Panel Testing at the San Antonio Breast Cancer Symposium. The study explored the relationship between pathogenic gene mutations and the biology of breast cancers. The objective of the study was to evaluate the utility of multi-gene panel testing in a comprehensive breast health practice. The study focused on patients who underwent panel testing from July 2013 to September 2014. Tests included at least 5 and up to 43 cancer-related genes. The study represents the first 500 patients who received multi-gene panel testing. The study found that only 6.3 percent of patients carried a pathogenic mutation. The majority of the mutations were the BRCA1 and BRCA2 variants, followed by CHEK2, ATM, and PALB2. The study discovered that multi-gene testing found more patients at risk for hereditary breast cancer than BRCA1 or BRCA2 testing alone, and that most patients with breast cancer and a pathogenic mutation will have a Luminal-type Ductal Carcinoma. Breastlink doctors believe that if the medical community better understands cancer biology, it will be able to figure out how to screen patients more effectively, what age MRIs need to be done, what prevention methods to use (e.g. Tamoxifen or Raloxifene), and better treatment algorithms. They also believe surgeons and oncologists at the forefront of treatment should talk to patients about the benefits and limitations of panel testing. To find out more about Breastlink, visit our website: www.breastlink.com
Views: 80 Breastlink Orange
El Paciente se entri evista con el Director del Establecimiento de Salud
 
03:06
El Paciente se entrevista con el Médico Director del Establecimiento de para exponer su descontento por la mala atención por parte de la Enfermera del Establecimiento de Salud
Views: 30 Rosita Maltez
Visiopharm: Detecting & Measuring Estrogen Receptor Expression in Parathyroid Tumors
 
28:18
Estrogen signaling has been proposed in parathyroid tumor genesis. In a recent publication, we found estrogen receptors present in parathyroid tissue and tumors. In addition to detecting the receptor, we have utilized scanner and image analysis technology to measure nuclear staining intensity of Estrogen Receptor beta within immunohistochemical slides. These expression data was correlated to clinical features of the patients. This presentation will cover the background, design, methodological issues and results from the published paper (jcem.endojournals.org/content/early/2012/09/27/jc.2012-2484).
Views: 49 Visiopharm
How to pronounce zoledronic acid (Reclast) (Memorizing Pharmacology Video Flashcard)
 
00:14
I've seen this as "zoledronate" which is like alendronate and ibandronate also. Pronunciation flashcards for the print, e-book, and pharmacology audiobook Memorizing Pharmacology: A Relaxed Approach. More difficult medication names will have two pronunciation videos, a flashcard short version and an extended version breaking the pronunciation down syllable by syllable.
Views: 668 Tony PharmD
The Price Is Right, Dom part 2
 
30:12
The Price Is Right 2008 Dom
Views: 2942 Richard Martinez
Gynecomastia: How To Get Rid Of Man Boobs
 
01:13
Gynecomastia correction is a procedure that addresses prominent male breasts. Some males develop breast tissue during puberty, which is not uncommon. Other times, males can develop breast tissue due to a hormonal imbalance. In order to address gynecomastia, also known as "man boobs", there are two different approaches. Dr. Z can use liposuction to remove excess fat and in severe cases, liposuction and direct incision will be required to remove the excess fat. Typically, surgery time is between 2-3 hours depending on the extent of your surgery. The recovery time is minimum which will only take a few days. OTHER HZ PLASTIC SURGERY PROCEDURES: -Breast Augmentation -Breast Lift -Breast Reduction -Breast Reconstruction -Gynecomastia -Tummy Tuck -Liposuction -Brazilian Butt Lift -Arm Lift -Thigh Lift -Body Lift -Vaginal Rejuvenation -Blepharoplasty -Face Lift -Rhinoplasty -Brow Lift -Ear Correction Learn more about all of our procedures here: http://bit.ly/2cDwqRt If you're interested in Gynecomastia Correction or any of the aforementioned procedures, contact us to schedule your FREE consultation: http://www.hzplasticsurgery.com/contact
Views: 125 HZPlasticSurgery
TRACO 2016: NSCLC and Cervical cancer
 
01:58:31
TRACO 2016: NSCLC and Cervical cancer Air date: Monday, November 7, 2016, 4:00:00 PM Category: TRACO Runtime: 01:58:31 Description: NSCLC and Cervical cancer For more information go to http://ccr.cancer.gov/trainee-resources-courses-workshops-traco Author: Eva Szabo, MD, NCI, NIH and John T. Schiller, Ph.D., NCI, NIH Permanent link: https://videocast.nih.gov/launch.asp?19993
Views: 214 nihvcast
slanker kaladawa
 
03:13
Deskripsi
Views: 154 sukron kaladawa